Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Aventis Appoints "General Manufacturing/Marketing Manager" Ahead of PAL Amendment
May 26, 2003
- Korosho Calls For Healthcare Supply System Reform Centered on Patients
May 26, 2003
- BULLETIN
May 26, 2003
- Japanese Firms May Not Feel Pain If There Is Pain: Mr Kobayashi of PhRMA
May 26, 2003
- Annual Business Results
May 26, 2003
- JPMA General Assembly
May 26, 2003
- ON THE MOVE
May 26, 2003
- Dear-Doctor Letter Doesn't Decrease Panaldine ADR Reports
May 26, 2003
- Wyeth Stresses Significance of Enbrel: Mr Essner
May 26, 2003
- GE Makers to Enjoy "Golden Years" Through FY2006: President of Taiyo
May 26, 2003
- Korosho to Link 1,000 Facilities via Clinical Trial Networks
May 26, 2003
- Non-majors Should Target Small Markets: Mr Seko of PMSRL
May 26, 2003
- Generic Package Inserts Need Improvement: Forum
May 26, 2003
- BUSINESS NEWS IN BRIEF
May 26, 2003
- MEDICAL FACILITIES & NURSING CARE NES IN BRIEF
May 26, 2003
- Website News
May 26, 2003
- Innovative Medical Care Procedures Should Be Patent-protected: METI
May 26, 2003
- Annual Business Results
May 26, 2003
- Fewer Children for 22nd Year in a Row: Somusho Statistics
May 26, 2003
- Annual Business Results
May 26, 2003
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…